Skip to content
Veroscience
  • News
  • Contact Us
  • Linkedin
  • Home
  • About Us
    • Executive Team
  • Cycloset
    • Cycloset Clinical Profile
    • Mechanism of Action
    • Pre-Clinical Studies
    • Clinical Studies
    • U.S. Cycloset Patents
    • www.cycloset.com
  • Pipeline
    • Cycloset for Pediatric T2DM Patients
    • VS41157 for Pancreatic Cancer
  • Technologies
    • Circadian Neuroendocrine Resetting Therapy (CNRT)
    • CNRT Overview Video References
    • Photo Immuno-Resetting Therapy for the Treatment of Cancer
  • Therapeutic Areas
    • Metabolic Diseases
    • Immunological Disorders
  • Partners & Collaborators
  • Publications
*Cycloset®

Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info

Home > News > Heart in Diabetes, 2nd Annual CME Conference
  • Share
      
  • Print

Heart in Diabetes, 2nd Annual CME Conference

https://www.heartindiabetes.com

Post navigation

VeroScience is Pleased to Support Independent Research from the Laboratory of Dr. DeFronzo and Team at UT Health Science Center, San Antonio
VeroScience Presents New Pipeline Data for Metabolic Disease Therapies at 2019 American Diabetes Association Meeting

Recent Comments

    Archives

    Categories

    • No categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • About Us
    • Executive Team
    • Cycloset
    • Cycloset Clinical Profile
    • Mechanism of Action
    • Pre-Clinical Studies
    • Clinical Studies
    • U.S. Cycloset Patents
    • www.cycloset.com
    • Pipeline
    • Cycloset for Pediatric T2DM Patients
    • VS41157 for Pancreatic Cancer
    • Technologies
    • Circadian Neuroendocrine Resetting Therapy (CNRT)
    • CNRT Overview Video References
    • Photo Immuno-Resetting Therapy for the Treatment of Cancer
    • Therapeutic Areas
    • Metabolic Diseases
    • Immunological Disorders
    close ×
    • Partners & Collaborators
    • News
    • Publications
    • Contact Us
    • Site Map
    • Terms of Use
    Website by Axxiem
    © Copyright . All Right Reserved
    By accessing our website or software provided by our third-party vendors, you consent to accept cookies, (including other identifiers). These include pieces of text that are stored on your computer or device. This site uses cookies and Google Analytics to improve navigation, minimize the need to reenter information previously entered on forms, personalize messages, and collect statistical information to improve site navigation and provide content of greatest interest to users.
    Cookie settingsACCEPT
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT